ALTO - Alto Ingredients, Inc.
NASDAQ
->
Basic Materials
->
Specialty Chemicals
Sacramento,
United States
Type: Equity
ALTO price evolution
ALTO
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $52.04 | $64.08 | $58.08 | $58.73 |
| Inventory | $48.01 | $49.43 | $42.61 | $52.61 |
| Total current assets | $145.15 | $153.66 | $150.84 | $168.77 |
| Long term investments | ||||
| Property, plant & equipment | $258.18 | $265.3 | $270.41 | $271.35 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $417.41 | $432.5 | $434.63 | $454.24 |
| Current liabilities | ||||
| Accounts payable | $17.2 | $20.13 | $18.51 | $20.75 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $45.1 | $49.77 | $55.05 | $65.29 |
| Long term debt | $83.34 | $90.96 | $84.07 | $82.1 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $153.49 | $166.68 | $165.98 | $174.68 |
| Shareholders' equity | ||||
| Retained earnings | -$782.13 | -$779.38 | -$775.95 | -$763.91 |
| Other shareholder equity | $2.48 | $2.48 | $2.48 | $2.48 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $47.67 | |||
| Short term investments | ||||
| Net receivables | $58.73 | $68.66 | $86.89 | $43.49 |
| Inventory | $52.61 | $66.63 | $54.37 | $41.77 |
| Total current assets | $168.77 | $199.12 | $229.53 | $214.05 |
| Long term investments | ||||
| Property, plant & equipment | $271.35 | $258.01 | $235.96 | $229.49 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $262.77 | |||
| Total investments | ||||
| Total assets | $454.24 | $478.32 | $484.95 | $476.82 |
| Current liabilities | ||||
| Accounts payable | $20.75 | $28.11 | $23.25 | $13.05 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $65.29 | $78.02 | $69.6 | $86.93 |
| Long term debt | $82.1 | $68.36 | $50.36 | $71.81 |
| Total noncurrent liabilities | $93.66 | |||
| Total debt | ||||
| Total liabilities | $174.68 | $170.23 | $139.74 | $180.58 |
| Shareholders' equity | ||||
| Retained earnings | -$763.91 | -$734.64 | -$691.78 | -$736.6 |
| Other shareholder equity | $2.48 | $1.82 | -$0.28 | -$3.88 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $251.81 | $236.47 | $240.63 | $273.63 |
| Cost of revenue | ||||
| Gross Profit | $5.96 | $7.55 | -$2.4 | -$2.52 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $7.51 | $8.96 | $7.93 | $8.38 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.1 | |||
| Interest expense | -$1.87 | -$1.67 | -$1.63 | -$2.13 |
| Net income | ||||
| Net income | -$2.76 | -$3.42 | -$12.04 | -$19.26 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1222.94 | $1335.6 | $897.02 | |
| Cost of revenue | ||||
| Gross Profit | $15.65 | -$27.6 | $52.86 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $32.66 | $31.5 | $43.17 | |
| Operating income | $9.85 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.1 | $1.9 | -$0.02 | |
| Interest expense | -$7.42 | -$1.8 | $17.94 | |
| Net income | ||||
| Net income | -$29.27 | -$42.9 | -$15.12 | |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$12.19 | -$12.1 | -$6.04 | -$33.03 |
| Financing activities | ||||
| Dividends paid | -$0.95 | -$0.63 | -$0.32 | -$1.26 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$1.07 | $7.33 | $1.21 | $6.96 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$6.99 | -$17.07 | -$3.41 | -$4.04 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Net income | -$17.28 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $71.78 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$33.03 | -$37.66 | $27.12 | $23.32 |
| Financing activities | ||||
| Dividends paid | -$1.26 | -$1.27 | -$2.85 | |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $6.96 | $19.01 | -$40 | -$66.42 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$4.04 | -$12.6 | $13.94 | $28.67 |
News
Fundamentals
| Market cap | $127.97M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 76.63M |
| Revenue | $1.00B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$37.49M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -3.41 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.13 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$0.49 |
|---|---|
| ROA | -8.62% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.22 |
| Quick ratio | 2.15 |